Intestinal inflammation and colorectal cancer: a double-edged sword?
about
Obesity and colorectal cancer: role of adipokines in tumor initiation and progressionCancer Risk in Patients With Empyema: A Nationwide Population-Based StudyThe role of astrocytes in CNS tumors: pre-clinical models and novel imaging approachesJoint network and node selection for pathway-based genomic data analysis.Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancerChronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismGenetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family RegistryUlcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?Systems analysis of inflammatory bowel disease based on comprehensive gene information.Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-γInvestigation of inflammation and tissue patterning in the gut using a Spatially Explicit General-purpose Model of Enteric Tissue (SEGMEnT).Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-κB Mediated Inflammation in Colon Cancer Patients.Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.Tube-like structures with co-expression of D2-40 and CD34: newly formed vasculatures?Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease.IκBKβ and NFκB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry.Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.Application of liposomes in drug development--focus on gastroenterological targets.An integrated approach to identify causal network modules of complex diseases with application to colorectal cancerVariation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease.The dual role of inflammation in colon carcinogenesisInflammatory Bowel Disease Associated Colorectal Neoplasia.Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice.Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers.Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitisLoss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice.The Application of Gene Expression Profiling in Predictions of Occult Lymph Node Metastasis in Colorectal Cancer Patients.Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation.
P2860
Q26853740-6E516FBB-8167-4A4D-84ED-2B48191F8D87Q27315538-D3412708-D60E-4A04-B885-2A557881DDB0Q30618244-D0E9A483-E970-48E2-8092-6487723EEB04Q30643757-2C48CAA2-87AB-44CA-AA3C-777143A3C385Q33614335-F3AF486B-BD29-4EFE-8CE2-F493A0B5F28AQ34001641-9BA33691-3D1C-4470-B144-1AFF6F937188Q34079481-ACB57E94-861B-4625-A2D8-21BDDEC9D730Q34096843-E3E6773C-CFE0-401D-9A20-5A1170529A1BQ34137246-EDA7501D-8518-4920-924E-A3176E87596FQ34223105-2CBE6105-E017-4A4B-A219-315585B89E3FQ34989005-1064A8C5-B966-4518-941C-52836135FC6AQ35133364-12703078-407D-4B96-8124-5DB80B1E716FQ35895151-4B5BB630-0FBD-4D8D-A2BF-53439177B9B3Q36316684-B4F35BB4-23BC-4252-974C-9082E04064D0Q36378151-2D87CC32-BCCE-4029-A4A5-03F7EA02C6EDQ36396805-CFFC2BFF-E7B7-4869-8CCD-49A1A2EB9AC8Q36499740-883C12CB-3F7A-4B83-9B0D-99BB98050010Q36733448-721B531F-2EBC-468E-A71A-9E93846B4DA9Q36758275-B5C759EB-869B-4495-A0E1-5B385EE30DC7Q37039848-02FC7434-021C-422F-A3EC-E628278C5EB3Q37367984-6CC73DA7-A11C-465A-834E-552700596852Q38056490-6CD56EC9-1B62-4370-BE66-19F95E51A7B8Q38201722-84A21233-D5EF-4BE3-B53E-E02854BBAA75Q38802590-9A843FCF-56F2-4DDC-97B8-51C1855D9C0AQ38824706-F766F45F-0BBD-483E-9489-4BB464541968Q39159902-5200D95B-F7DD-42C7-B49B-65DA82F3BD90Q41612495-F1E108DF-11A2-4885-936E-E95C8AC88853Q42430892-C08C89F4-51EC-4A34-93E9-6DB85C06F406Q42630337-38626489-410D-45BE-AD3A-377D1122B88CQ51315488-98FA984E-934D-4520-AAE4-23AA3DE17809Q54693967-6F083C73-B863-452D-8969-C1311DA4874DQ54918017-1A09B26F-43E5-4B3E-B24F-216EC8164CC3
P2860
Intestinal inflammation and colorectal cancer: a double-edged sword?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Intestinal inflammation and colorectal cancer: a double-edged sword?
@en
Intestinal inflammation and colorectal cancer: a double-edged sword?
@nl
type
label
Intestinal inflammation and colorectal cancer: a double-edged sword?
@en
Intestinal inflammation and colorectal cancer: a double-edged sword?
@nl
prefLabel
Intestinal inflammation and colorectal cancer: a double-edged sword?
@en
Intestinal inflammation and colorectal cancer: a double-edged sword?
@nl
P2093
P2860
P356
P1476
Intestinal inflammation and colorectal cancer: a double-edged sword?
@en
P2093
Angelamaria Rizzo
Francesco Pallone
Giovanni Monteleone
Massimo Claudio Fantini
P2860
P304
P356
10.3748/WJG.V17.I26.3092
P407
P577
2011-07-01T00:00:00Z